sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
全身麻酔薬剤市場 - 世界の機会分析および産業予測

全身麻酔薬剤市場 - 世界の機会分析および産業予測

Home / Categories / Healthcare
全身麻酔薬剤市場 - 世界の機会分析および産業予測
全身麻酔薬剤市場 - 世界の機会分析および産業予測
Report Code
RO13/139/1004

Publish Date
19/May/2024

Pages
200
PRICE
$ 4450/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5450/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 6450/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

Table 1. Global General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 2. General Anesthesia Drugs Market Revenue, for Propofol, by Region, 2021-2030, ($Million)
Table 3. General Anesthesia Drugs Market for Propofol by Country, 2021-2030, ($Million)
Table 4. General Anesthesia Drugs Market Revenue, for Sevoflurane, by Region, 2021-2030, ($Million)
Table 5. General Anesthesia Drugs Market for Sevoflurane by Country, 2021-2030, ($Million)
Table 6. General Anesthesia Drugs Market Revenue, for Desflurane, by Region, 2021-2030, ($Million)
Table 7. General Anesthesia Drugs Market for Desflurane by Country, 2021-2030, ($Million)
Table 8. General Anesthesia Drugs Market Revenue, for Others, by Region, 2021-2030, ($Million)
Table 9. General Anesthesia Drugs Market for Others by Country, 2021-2030, ($Million)
Table 10. Global General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 11. General Anesthesia Drugs Market Revenue, for Intravenous, by Region, 2021-2030, ($Million)
Table 12. General Anesthesia Drugs Market for Intravenous by Country, 2021-2030, ($Million)
Table 13. General Anesthesia Drugs Market Revenue, for Inhalation, by Region, 2021-2030, ($Million)
Table 14. General Anesthesia Drugs Market for Inhalation by Country, 2021-2030, ($Million)
Table 15. Global General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 16. General Anesthesia Drugs Market Revenue, for Knee and Hip Replacements, by Region, 2021-2030, ($Million)
Table 17. General Anesthesia Drugs Market for Knee and Hip Replacements by Country, 2021-2030, ($Million)
Table 18. General Anesthesia Drugs Market Revenue, for Heart Surgeries, by Region, 2021-2030, ($Million)
Table 19. General Anesthesia Drugs Market for Heart Surgeries by Country, 2021-2030, ($Million)
Table 20. General Anesthesia Drugs Market Revenue, for Cancer Surgery, by Region, 2021-2030, ($Million)
Table 21. General Anesthesia Drugs Market for Cancer Surgery by Country, 2021-2030, ($Million)
Table 22. General Anesthesia Drugs Market Revenue, for General Surgery, by Region, 2021-2030, ($Million)
Table 23. General Anesthesia Drugs Market for General Surgery by Country, 2021-2030, ($Million)
Table 24. Global General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 25. General Anesthesia Drugs Market Revenue, for Hospital, by Region, 2021-2030, ($Million)
Table 26. General Anesthesia Drugs Market for Hospital by Country, 2021-2030, ($Million)
Table 27. General Anesthesia Drugs Market Revenue, for Ambulatory Surgical Centers, by Region, 2021-2030, ($Million)
Table 28. General Anesthesia Drugs Market for Ambulatory Surgical Centers by Country, 2021-2030, ($Million)
Table 29. General Anesthesia Drugs Market, by Region, 2021-2030, ($Million)
Table 30. North America General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 31. North America General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 32. North America General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 33. North America General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 34. North America General Anesthesia Drugs Market, by Country, 2021-2030, ($Million)
Table 35. U.S. General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 36. U.S. General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 37. U.S. General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 38. U.S. General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 39. Canada General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 40. Canada General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 41. Canada General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 42. Canada General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 43. Mexico General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 44. Mexico General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 45. Mexico General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 46. Mexico General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 47. Europe General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 48. Europe General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 49. Europe General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 50. Europe General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 51. Europe General Anesthesia Drugs Market, by Country, 2021-2030, ($Million)
Table 52. Germany General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 53. Germany General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 54. Germany General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 55. Germany General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 56. France General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 57. France General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 58. France General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 59. France General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 60. U.K. General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 61. U.K. General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 62. U.K. General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 63. U.K. General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 64. Italy General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 65. Italy General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 66. Italy General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 67. Italy General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 68. Spain General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 69. Spain General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 70. Spain General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 71. Spain General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 72. Rest of Europe General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 73. Rest of Europe General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 74. Rest of Europe General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 75. Rest of Europe General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 76. Asia-Pacific General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 77. Asia-Pacific General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 78. Asia-Pacific General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 79. Asia-Pacific General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 80. Asia-Pacific General Anesthesia Drugs Market, by Country, 2021-2030, ($Million)
Table 81. China General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 82. China General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 83. China General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 84. China General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 85. Japan General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 86. Japan General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 87. Japan General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 88. Japan General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 89. India General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 90. India General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 91. India General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 92. India General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 93. Australia General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 94. Australia General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 95. Australia General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 96. Australia General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 97. South Korea General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 98. South Korea General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 99. South Korea General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 100. South Korea General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 101. Rest of Asia-Pacific General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 102. Rest of Asia-Pacific General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 103. Rest of Asia-Pacific General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 104. Rest of Asia-Pacific General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 105. LAMEA General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 106. LAMEA General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 107. LAMEA General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 108. LAMEA General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 109. LAMEA General Anesthesia Drugs Market, by Country, 2021-2030, ($Million)
Table 110. Brazil General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 111. Brazil General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 112. Brazil General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 113. Brazil General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 114. Saudi Arabia General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 115. Saudi Arabia General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 116. Saudi Arabia General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 117. Saudi Arabia General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 118. South Africa General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 119. South Africa General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 120. South Africa General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 121. South Africa General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 122. Rest of LAMEA General Anesthesia Drugs Market, by Type of Drugs, 2021-2030, ($Million)
Table 123. Rest of LAMEA General Anesthesia Drugs Market, by Route of Administration, 2021-2030, ($Million)
Table 124. Rest of LAMEA General Anesthesia Drugs Market, by Surgery Type, 2021-2030, ($Million)
Table 125. Rest of LAMEA General Anesthesia Drugs Market, by End-user, 2021-2030, ($Million)
Table 126. B. Braun Melsungen: Company Snapshot
Table 127. B. Braun Melsungen: Operating Segments
Table 128. B. Braun Melsungen: Product Portfolio
Table 129. B. Braun Melsungen: Net Sales
Table 130. B. Braun Melsungen: Key Stratergies
Table 131. Baxter International Inc.: Company Snapshot
Table 132. Baxter International Inc.: Operating Segments
Table 133. Baxter International Inc.: Product Portfolio
Table 134. Baxter International Inc.: Net Sales
Table 135. Baxter International Inc.: Key Strategies
Table 136. Fresenius Se and Co. KGaA: Company Snapshot
Table 137. Fresenius Se and Co. KGaA: Operating Segments
Table 138. Fresenius Se and Co. KGaA: Product Portfolio
Table 139. Fresenius Se and Co. KGaA: Net Sales
Table 140. Fresenius Se and Co. KGaA: Key Stratergies
Table 141. Hikma Pharmaceuticals plc: Company Snapshot
Table 142. Hikma Pharmaceuticals plc: Operating Segments
Table 143. Hikma Pharmaceuticals plc: Product Portfolio
Table 144. Hikma Pharmaceuticals plc: Net Sales
Table 145. Hikma Pharmaceuticals plc: Key Strategies
Table 146. Paion Ag: Company Snapshot
Table 147. Paion Ag: Operating Segments
Table 148. Paion Ag: Product Portfolio
Table 149. Paion Ag: Net Sales
Table 150. Paion Ag: Key Strategies
Table 151. Pfizer Inc.: Company Snapshot
Table 152. Pfizer Inc.: Operating Segments
Table 153. Pfizer Inc.: Product Portfolio
Table 154. Pfizer Inc.: Net Sales
Table 155. Pfizer Inc.: Key Strategies
Table 156. Abbott Laboratories: Company Snapshot
Table 157. Abbott Laboratories: Operating Segments
Table 158. Abbott Laboratories: Product Portfolio
Table 159. Abbott Laboratories: Net Sales
Table 160. Abbott Laboratories: Key Strategies
Table 161. Abbvie Inc: Company Snapshot
Table 162. Abbvie Inc: Operating Segments
Table 163. Abbvie Inc: Product Portfolio
Table 164. Abbvie Inc: Net Sales
Table 165. Abbvie Inc: Key Strategies
Table 166. Astrazeneca plc: Company Snapshot
Table 167. Astrazeneca plc: Operating Segments
Table 168. Astrazeneca plc: Product Portfolio
Table 169. Astrazeneca plc: Net Sales
Table 170. Astrazeneca plc: Key Stratergies
Table 171. Avet Pharmaceuticals Inc: Company Snapshot
Table 172. Avet Pharmaceuticals Inc: Operating Segments
Table 173. Avet Pharmaceuticals Inc: Product Portfolio
Table 174. Avet Pharmaceuticals Inc: Net Sales
Table 175. Avet Pharmaceuticals Inc: Key Strategies

LIST OF FIGURE

Figure 1. General Anesthesia Drugs Market Segmentation
Figure 2. General Anesthesia Drugs Market, 2021-2030
Figure 3. General Anesthesia Drugs Market, 2021-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. General Anesthesia Drugs Market: Drivers, Restraints and Opportunities
Figure 12. General Anesthesia Drugs Market, by Type of Drugs, 2021 (%)
Figure 13. Comparative Share Analysis of Propofol General Anesthesia Drugs Market, 2021-2030 (%)
Figure 14. Comparative Share Analysis of Sevoflurane General Anesthesia Drugs Market, 2021-2030 (%)
Figure 15. Comparative Share Analysis of Desflurane General Anesthesia Drugs Market, 2021-2030 (%)
Figure 16. Comparative Share Analysis of Others General Anesthesia Drugs Market, 2021-2030 (%)
Figure 17. General Anesthesia Drugs Market, by Route of Administration, 2021 (%)
Figure 18. Comparative Share Analysis of Intravenous General Anesthesia Drugs Market, 2021-2030 (%)
Figure 19. Comparative Share Analysis of Inhalation General Anesthesia Drugs Market, 2021-2030 (%)
Figure 20. General Anesthesia Drugs Market, by Surgery Type, 2021 (%)
Figure 21. Comparative Share Analysis of Knee and Hip Replacements General Anesthesia Drugs Market, 2021-2030 (%)
Figure 22. Comparative Share Analysis of Heart Surgeries General Anesthesia Drugs Market, 2021-2030 (%)
Figure 23. Comparative Share Analysis of Cancer Surgery General Anesthesia Drugs Market, 2021-2030 (%)
Figure 24. Comparative Share Analysis of General Surgery General Anesthesia Drugs Market, 2021-2030 (%)
Figure 25. General Anesthesia Drugs Market, by End-user, 2021 (%)
Figure 26. Comparative Share Analysis of Hospital General Anesthesia Drugs Market, 2021-2030 (%)
Figure 27. Comparative Share Analysis of Ambulatory Surgical Centers General Anesthesia Drugs Market, 2021-2030 (%)
Figure 28. General Anesthesia Drugs Market by Region, 2021
Figure 29. U.S. General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 30. Canada General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 31. Mexico General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 32. Germany General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 33. France General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 34. U.K. General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 35. Italy General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 36. Spain General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 37. Rest of Europe General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 38. China General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 39. Japan General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 40. India General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 41. Australia General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 42. South Korea General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 43. Rest of Asia-Pacific General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 44. Brazil General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 45. Saudi Arabia General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 46. South Africa General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 47. Rest of LAMEA General Anesthesia Drugs Market, 2021-2030 ($Million)
Figure 48. Top Winning Strategies, by Year
Figure 49. Top Winning Strategies, by Development
Figure 50. Top Winning Strategies, by Company
Figure 51. Product Mapping of Top 10 Players
Figure 52. Competitive Dashboard
Figure 53. Competitive Heatmap of Top 10 Key Players
Figure 54. B. Braun Melsungen.: Net Sales, ($Million)
Figure 55. Baxter International Inc. Net Sales, ($Million)
Figure 56. Fresenius SE and Co. KGaA.: Net Sales, ($Million)
Figure 57. Hikma Pharmaceuticals PLC.: Net Sales, ($Million)
Figure 58. Paion AG.: Net Sales, ($Million)
Figure 59. Pfizer Inc. Net Sales, ($Million)
Figure 60. Abbott Laboratories.: Net Sales, ($Million)
Figure 61. Abbvie Inc.: Net Sales, ($Million)
Figure 62. Astrazeneca PLC.: Net Sales, ($Million)
Figure 63. Avet Pharmaceuticals Inc.: Net Sales, ($Million)

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com